Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-6-1
|
pubmed:abstractText |
This study examined the dose-response effects of caffeine on plasma K+ balance during prolonged exercise. Two series of experiments were performed. In series A, 1 h after ingestion of 9 mg/kg dextrose (placebo) or 9 mg/kg caffeine, eight subjects cycled at 78% of peak O2 consumption until exhaustion; in series B, in four trials, 1 h after ingestion of 0, 3, 6, or 9 mg/kg caffeine, eight subjects ran on a treadmill at 85% of peak O2 consumption until exhaustion. Blood was sampled from an antecubital vein for analysis of hematocrit, plasma concentrations of epinephrine ([Epi]) and norepinephrine, and [K+]. The change in plasma volume was calculated from hematocrit. During exercise, there was a net addition of K+ to and a net loss of fluid from the plasma compartment. Caffeine had no effect on plasma volume and norepinephrine concentration during exercise. In series A and B 9 mg/kg caffeine and in series B 6 mg/kg caffeine resulted in a significant attenuation of the increase in plasma [K+] with exercise. In series A increases in plasma [Epi] were 1.4- to 2-fold greater during exercise with caffeine than with placebo. At exhaustion, plasma [Epi] was twofold higher with caffeine (10.1 +/- 2.3 nM) than with placebo (5.3 +/- 0.8 nM), whereas plasma [K+] was only 4.88 +/- 0.18 meq/l with caffeine compared with 5.37 +/- 0.14 meq/l with placebo. It is concluded that caffeine attenuates the increase in plasma [K+] during exercise by stimulation (via one of its metabolites or by increased [Epi]) of tissue Na-K pump activity.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Caffeine,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Chlorides,
http://linkedlifedata.com/resource/pubmed/chemical/Potassium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Potassium-Exchanging ATPase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
8750-7587
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1149-55
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8387071-Adult,
pubmed-meshheading:8387071-Blood Glucose,
pubmed-meshheading:8387071-Caffeine,
pubmed-meshheading:8387071-Catecholamines,
pubmed-meshheading:8387071-Chlorides,
pubmed-meshheading:8387071-Exercise,
pubmed-meshheading:8387071-Female,
pubmed-meshheading:8387071-Hemostasis,
pubmed-meshheading:8387071-Humans,
pubmed-meshheading:8387071-Male,
pubmed-meshheading:8387071-Oxygen Consumption,
pubmed-meshheading:8387071-Potassium,
pubmed-meshheading:8387071-Sodium,
pubmed-meshheading:8387071-Sodium-Potassium-Exchanging ATPase,
pubmed-meshheading:8387071-Water-Electrolyte Balance
|
pubmed:year |
1993
|
pubmed:articleTitle |
Caffeine attenuates the exercise-induced increase in plasma [K+] in humans.
|
pubmed:affiliation |
School of Human Biology, University of Guelph, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|